Silmedic Sp. z o.o.

At Silmedic Sp. z o.o. in Katowice, clinical trials in cardiovascular diseases and nutritional and metabolic disorders focus on major conditions such as atrial fibrillation, hypertension, atherosclerotic cardiovascular disease, obesity, and hyperuricemia associated with gout. These studies are designed to assess new treatment options and better understand how to reduce the risk of serious heart and vascular events.

• Research on atrial fibrillation and stroke prevention
• Trials in uncontrolled and resistant hypertension
• Studies for atherosclerotic cardiovascular disease and broader cardiovascular risk reduction
• Evaluation of therapies for gout and hyperuricemia

Overall, this area combines treatment testing with efforts to improve long-term cardiovascular protection and metabolic control.

The site has a strong focus on nervous system diseases, especially migraine in its chronic, episodic, menstrual, and acute forms. Trials also include early Parkinson’s disease and Alzheimer’s disease-related agitation, reflecting research aimed at improving symptom control, prevention, and day-to-day functioning for people with neurological conditions.

• Prevention and treatment studies for chronic migraine, episodic migraine, and menstrual migraine
• Research on early Parkinson’s disease and disease progression
• Trials addressing agitation in Alzheimer’s disease dementia
• Evaluation of therapies for both symptom relief and long-term tolerability

These studies aim to expand options for common and disabling neurological disorders while improving everyday quality of life.

Clinical research at this hospital/clinic also covers musculoskeletal diseases and pain-related conditions, including rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, osteoarthritis of the knee, and several forms of neuropathic pain and chronic low back pain. The studies are largely centered on testing new therapies and comparing their effectiveness for persistent pain and inflammatory joint disease.

• Trials in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis
• Studies for chronic neuropathic pain, post-surgical neuropathic pain, and diabetic peripheral neuropathic pain
• Research on chronic non-specific low back pain and knee osteoarthritis
• Comparisons of new treatments with existing care to improve pain relief and function

This therapeutic area is especially active in evaluating better ways to manage pain, inflammation, and mobility limitations.

Trials in respiratory tract diseases and immune system diseases include studies in asthma and respiratory syncytial virus infections, along with immune-mediated conditions such as atopic dermatitis. The research aims to assess new treatments, preventive approaches, and immune responses in both chronic and infectious diseases.

• Studies in moderate-to-severe uncontrolled asthma and controlled asthma
• Research on respiratory syncytial virus prevention and immune response
• Trials for atopic dermatitis as an inflammatory skin and immune condition
• Evaluation of treatment effectiveness and safety across respiratory and immune disorders

These investigations support better disease control and help clarify how new therapies may work in everyday clinical practice.

Another important research focus at Silmedic Sp. z o.o. is skin and connective tissue diseases together with female urogenital diseases and pregnancy-related conditions. Studies involve acne vulgaris, primary dysmenorrhea, and other inflammatory disorders, with the goal of improving symptom relief, tolerability, and treatment options for common outpatient conditions.

• Trials for acne vulgaris exploring new topical treatments
• Research on primary dysmenorrhea to reduce menstrual pain
• Studies in inflammatory and immune-linked skin conditions
• Work focused on improving comfort, safety, and real-world treatment usefulness

These studies address conditions that can strongly affect daily comfort and quality of life, especially in younger and working-age populations.